(AOF) – Novacyt, an international specialist in clinical diagnostics, “takes note” of the announcement made by Yourgene Health concerning the offer made by its subsidiary Novacyt UK Holdings Limited for the entire share capital of Yourgene announced on July 3, 2023. Yourgene today announced that, following an application to the London Stock Exchange, admission to trading on AIM of Yourgene shares has been canceled with effect from 7:00 a.m. today, 11 September 2023.
© 2023 Agence Option Finance (AOF) – All rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends with the buttons below.
